Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation: a randomized clinical trial

Citation:

E.B. Foa, Simpson, H.B. , Gallagher, T. , Wheaton, M.G. , Gershkovich, M. , Schmidt, A.B. , Huppert, J.D. , Imms, P. , Campeus, RC , Cahill, SP. , DiChiara, C. , Tsao, S , Puliafico, A , Chazin, D , Asnaani, A , Moore, K , Tyler, J. , Steinman, SA , Sanchez-LaCay, A , Capaldi, S , Snorrason, Í, Turk-Karan, E. , Vermes, D, Kalanthroff, E. , Pinto, A. , Hamlett, G. , Middleton, R , Hahn, C , Xu, B , Van Meter, P , Katechis, M , and Rosenfield, D.. 2022. “Maintenance Of Wellness In Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation: A Randomized Clinical Trial”. Jama Psychiatry.